Dosage Form Design Flashcards

1
Q

Definition of Drug

A

An agent intended for use in the diagnosis, mitigation, treatment cure or prevention of disease in humans/animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Chemical syntheses is the major source of drug for most compounds due to what?

A

Advancements in chemistry, purification and engineering

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the four main sources of drug compounds?

A

Chemical syntheses
Plants
Animals
Humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define drug delivery

A

Development of the most appropriate dosage form (preparation, formulations) that allow for patient to take the medication in the most convenient and acceptable manner

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define “Dosage Forms”

A

Any physical form that consists of both active ingredients and pharmaceutical excipients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How many medication doses do most dosage forms usually contain?

A

One

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the 6 major reasons to make appropriate dosage forms out of drug compounds?

A

1) To prevent active ingredients from degradation (physical/chemical/biological, in vitro and in vivo)
2) To conceal unpleasant flavor, taste or odor of active ingredients or pharmaceutical excipients
3) To facilitate mass industrial production of drug products
4) To use accurate dose of active ingredients
5) To provide various product choices to patients and consumers
6) To enhance therapeutic compliance and outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the major goal of drug delivery?

A

To obtain the highest drug effects in the simplest administration way

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Routes of drug administrations:

A

Oral, parenteral, transdermal, nasal, buccal, sublingual, ophthalmics, pulmonary, rectal, topical, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Therapeutic effects can be either:

A

Systemic or Site-specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

True or False: Systemic products can only have systemic effects

A

False: systemic formulations can have site specific effects and topical formulations can have systemic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the 6 stages in drug discovery that must be done before becoming a product for human application?

A

1) New Chemical Entity
2) Preclinical Studies
3) Investigational New Drug Application
4) Clinical Trials
5) New Drug Application
6) Post-marketing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The finding of a compound as a potential drug candidate is apart of what stage?

A

1) New chemical entity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is entailed in finding a New Chemical Entity?

A

Syntheses, extraction, separation and purification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do Preclinical Studies determine?

A

The suitability of an NCE as a therapeutic agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What do preclinical studies investigate?

A

Early stage: physical/chemical characterization, pharmacological/toxicological evaluations and in vivo behaviours.
Late stage: long term toxicity, formulation development/assessment, and prep for new drug product launch.

17
Q

When can clinical trials on human subjects begin?

A

After the health authority has reviewed the Investigational New Drug application and approved it for safety.

18
Q

Describe the three phases of clinical trials.

A

1) drug safety in 20-100 subjects
2) drug efficacy in 100’s of people
3) drug efficacy and evaluation in 1000’s of people

19
Q

What is involved in the New Drug Application?

A

Submission of complete information of a chemical entity for review by the health authorities, including everything from physiochemical characterization, pharmacology, toxicology, clinical results, to formation, production and quality control.

20
Q

How long does it take for a new drug product to go through whole process?

A

5-10 years

21
Q

What are the two major areas that are explored completely before final decision is made to market?

A

Drugs In vitro

Drugs In vivo

22
Q

In vitro drug testing includes:

A

Assessing basic characteristics of chemical compounds (physical and chemical properties, interaction with other dugs, stability)

23
Q

What are the four biological stages in vivo that all drugs undergo?

A

Absorption
Distribution
Metabolism
Excretion

24
Q

Bioavailability is one of the principle criteria to evaluate effectiveness of dose form, define it.

A

The rate and extent of an active ingredient from a formulation to the site of action

25
Q

The comparison of bioavailability of different formulations, batches or products with the same active ingredient

A

Bioequivalence

26
Q

What causes differences in bioequivalence between the same product from different drug companies?

A

Different:
Manufacturing processes
Excipients used
Quality Control measures of company

27
Q

What is the formulation goal?

A

Make most optimal dosage form for specific purpose

28
Q

What administration route achieves the fastest onset?

A

Parenteral

29
Q

What is the most commonly used and most accepted dosage formulation?

A

Oral

30
Q

Formulation with the longest effect, easiest application but slower onset?

A

Transdermal

31
Q

What are the benefits of modifying the drug release rate through excipients?

A
  • sustaining absorption in GI
  • prolonging systemic effects of drug
  • decreasing administration frequency
  • decreasing potential adverse effects
32
Q

Four factors to consider in drug development.

A

Physiochemical properties
Biological characteristics
Route of administration
Excipients properties

33
Q

What are some common excipients?

A

Suspending agents (stability, dose accuracy)
Binders (disintegration, dissolution, bioavailability)
Emulsifiers (particle size, O/W or W/O, stability)
Lubricants (dissolution, bioavailability)

34
Q

True or False: Excipients only have positive effects on formulation, such as enhancing appearance, concealing unfavourable taste/smell,and increasing bioavailability.

A

False. They can also have negative effects on the formulation.

35
Q

What does MEC and MTC stand for?

A

MEC- minimal effective concentration
MTC- minimal toxic concentration
Blood concentrations should be in between these two.

36
Q

What needs to be considered for optimal drug therapy?

A

Drug interactions
Subject situation
Drug tolerance
Patient compliance

37
Q

Where is the future going in drug formulation?

A

More personalized medications and bioavailability improvements